This inventor holds 1 USPTO granted patent. Top assignee: Zeneca Limited. Active years: 1996.
Company Filing History:
Years Active: 1996
Title: Maj E Markstedt: Innovator in Pharmaceutical Compositions
Introduction
Maj E Markstedt is a notable inventor based in Billdal, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hereditary tyrosinemia. Her innovative work has led to the development of novel compositions that hold promise for patients suffering from this metabolic disorder.
Latest Patents
Maj E Markstedt holds 1 patent for her invention titled "Pharmaceutical compositions for the treatment of hereditary tyrosinemia." This invention focuses on pharmaceutical compositions that contain a 2-benzoyl-1,3-cyclohexanedione as an active ingredient. This compound acts as an inhibitor of the enzyme 4-hydroxyphenylpyruvate dioxygenase (HPPD), which is crucial in the metabolic pathways affected by tyrosinemia type I.
Career Highlights
Throughout her career, Maj E Markstedt has been associated with Zeneca Limited, where she has contributed her expertise in pharmaceutical research and development. Her work has been instrumental in advancing treatments for metabolic disorders, showcasing her dedication to improving patient outcomes.
Collaborations
Maj has collaborated with esteemed colleagues such as Sven T Lindstedt and Michael P Prisbylla. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.
Conclusion
Maj E Markstedt's contributions to pharmaceutical compositions represent a significant advancement in the treatment of hereditary tyrosinemia. Her innovative spirit and dedication to research continue to inspire progress in the field of medicine.